NYSE: LLY - Eli Lilly and Company

Yield per half year: -11.03%
Dividend yield: +0.61%
Sector: Healthcare

Company Analysis Eli Lilly and Company

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (8.45%) is higher than the sector average (-18.38%).
  • Current debt level 39.41% is below 100% and has decreased over 5 years from 40.21%.
  • The company's current efficiency (ROE=48.65%) is higher than the sector average (ROE=-82.41%)

Disadvantages

  • Price (821.86 $) is higher than fair price (69.12 $)
  • Dividends (0.6068%) are below the sector average (1.31%).

Similar companies

Humana

UnitedHealth Group

Bristol-Myers

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Eli Lilly and Company Healthcare Index
7 days -10% -13.3% 2.7%
90 days 5.1% -13% -4.5%
1 year 8.4% -18.4% 10%

LLY vs Sector: Eli Lilly and Company has outperformed the "Healthcare" sector by 26.83% over the past year.

LLY vs Market: Eli Lilly and Company has underperformed the market marginally by -1.59% over the past year.

Stable price: LLY is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: LLY with weekly volatility of 0.1625% over the past year.

3. Summary of the report

3.1. General

P/E: 98.32
P/S: 15.1

3.2. Revenue

EPS 5.8
ROE 48.65%
ROA 8.19%
ROIC 26.2%
Ebitda margin 36.5%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (821.86 $) is higher than the fair price (69.12 $).

Price is higher than fair: The current price (821.86 $) is 91.6% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (98.32) is lower than that of the sector as a whole (114.26).

P/E vs Market: The company's P/E (98.32) is higher than that of the market as a whole (73.05).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (47.43) is higher than that of the sector as a whole (9.02).

P/BV vs Market: The company's P/BV (47.43) is higher than that of the market as a whole (22.32).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (15.1) is higher than that of the sector as a whole (4.1).

P/S vs Market: The company's P/S indicator (15.1) is lower than that of the market as a whole (15.91).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (43.16) is higher than that of the sector as a whole (17.72).

EV/Ebitda vs Market: The company's EV/Ebitda (43.16) is higher than that of the market as a whole (23.05).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -3.07% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-3.07%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).

5.4. ROE

ROE vs Sector: The company's ROE (48.65%) is higher than that of the sector as a whole (-82.41%).

ROE vs Market: The company's ROE (48.65%) is higher than that of the market as a whole (25.12%).

5.5. ROA

ROA vs Sector: The company's ROA (8.19%) is higher than that of the sector as a whole (6.75%).

ROA vs Market: The company's ROA (8.19%) is higher than that of the market as a whole (6.65%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (26.2%) is higher than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (26.2%) is higher than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (39.41%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 40.21% to 39.41%.

Excess of debt: The debt is not covered by net income, percentage 481.36%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0.6068% is below the average for the sector '1.31%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 0.6068% has been steadily paid over the past 7 years, DSI=1.

Dividend growth: Company's dividend yield 0.6068% has been growing over the last 5 years. Growth over 10 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (77.65%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 32.36% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Eli Lilly and Company

9.3. Comments